Baidu
map

Neurology:2型糖尿病可炎性相关脑血流量下降可能与认知功能障碍有关

2015-07-13 MedSci MedSci原创

2型糖尿病可致认知功能障碍研究人员发现,仅仅过去了2年,2型糖尿病患者调节血流量的能力便已降低,由此影响了他们的认知和行为能力。采用队列研究的方法,纳入40名研究对象,19名2型糖尿病患者及21名无糖尿病患者,平均年龄为66岁。19名2型糖尿病患者均已接受5年以上的治疗,平均治疗时间为13年。该研究中,研究人员还对研究对象进行了一系列的测试,评估了他们的认知和记忆功能,同时还使用MRI扫描成像,血


研究人员发现,仅仅过去了2年,2型糖尿病患者调节血流量的能力便已降低,由此影响了他们的认知和行为能力。

采用队列研究的方法,纳入40名研究对象,19名2型糖尿病患者及21名无糖尿病患者,平均年龄为66岁。19名2型糖尿病患者均已接受5年以上的治疗,平均治疗时间为13年。

该研究中,研究人员还对研究对象进行了一系列的测试,评估了他们的认知和记忆功能,同时还使用MRI扫描成像,血液测试以评估机体脑体积,血流量及炎症情况。2年后重复这些测量。

他们发现,2型糖尿病患者的脑血量调节能力下降了,且认知和记忆功能也较2年前较差。研究开始时血流量调节能力最差的研究对象其最基本的日常事务(如洗澡和烹饪)的执行能力下降最多。此外,研究人员发现,炎症程度最高的研究对象不论其血糖或血压是否已控制,其血流量调节能力下降的幅度也最大。

血流量的检测可预测机体的认知变化

在2年的研究过程中,与不伴有2型糖尿病的个体相比,2型糖尿病患者的学习和记忆能力明显较低。2型糖尿病患者的平均测试得分下降了12%,从46分降到41分,而不伴有2型糖尿病的研究对象其平均测试得分则稳定在55分。研究人员发现,2型糖尿病患者的血流量调节能力在过去的2年里下降了65%左右。

“早期发现并检测血流量调节能力是预测机体认知和决策能力加速变化的一个重要手段,”Dr. Novak 说道。

由于研究仅在研究开始时以及2年后研究结束时对研究对象进行了测试,因此无法得知2型糖尿病患者的认知和行为能力是如何随时间而变化的。作者也承认此为本研究的局限性,他指出需要开始另一项样本量更大,时间更久的研究,以进一步揭示血流量调节与疾病之间的时间关系。

本研究还存在其他的局限性,研究人员并没有测量其他可能导致认知受损的因素,且研究并未纳入年轻患者。

尽管存在这些局限性,作者认为他们的研究仍可为关于2型糖尿病对大脑长期影响的机制提供了临床证据,影响了老年2型糖尿病患者的卫生保健以及将来的治疗。

原始出处:

Chung CC, Pimentel D, Jor'dan AJ, Hao Y, Milberg W, Novak V.Inflammation-associated declines in cerebral vasoreactivity and cognition in type 2diabetes. Neurology. 2015 Jul 8. pii: 10.1212/WNL.0000000000001820.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1999538, encodeId=f5881999538b1, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Wed Aug 19 15:07:00 CST 2015, time=2015-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2075889, encodeId=c73720e588947, content=<a href='/topic/show?id=b208891e986' target=_blank style='color:#2F92EE;'>#血流量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89179, encryptionId=b208891e986, topicName=血流量)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a691420, createdName=30397604, createdTime=Wed Jul 15 01:07:00 CST 2015, time=2015-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2042252, encodeId=1c70204225211, content=<a href='/topic/show?id=754b8508329' target=_blank style='color:#2F92EE;'>#脑血流#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85083, encryptionId=754b8508329, topicName=脑血流)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b191324, createdName=marongnuan, createdTime=Sat Feb 20 12:07:00 CST 2016, time=2016-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35066, encodeId=6ff435066a8, content=期待有更多研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Thu Aug 06 23:03:00 CST 2015, time=2015-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1421022, encodeId=45681421022f6, content=<a href='/topic/show?id=09d33294eb8' target=_blank style='color:#2F92EE;'>#功能障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32947, encryptionId=09d33294eb8, topicName=功能障碍)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3493649807, createdName=naiwu78, createdTime=Wed Jul 15 03:07:00 CST 2015, time=2015-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=32638, encodeId=eed232638c3, content=完蛋咯, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150707/IMG559BDBCBCA5618647.jpg, createdBy=494c1631012, createdName=文刀, createdTime=Mon Jul 13 22:35:00 CST 2015, time=2015-07-13, status=1, ipAttribution=)]
    2015-08-19 yinhl1978
  2. [GetPortalCommentsPageByObjectIdResponse(id=1999538, encodeId=f5881999538b1, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Wed Aug 19 15:07:00 CST 2015, time=2015-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2075889, encodeId=c73720e588947, content=<a href='/topic/show?id=b208891e986' target=_blank style='color:#2F92EE;'>#血流量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89179, encryptionId=b208891e986, topicName=血流量)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a691420, createdName=30397604, createdTime=Wed Jul 15 01:07:00 CST 2015, time=2015-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2042252, encodeId=1c70204225211, content=<a href='/topic/show?id=754b8508329' target=_blank style='color:#2F92EE;'>#脑血流#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85083, encryptionId=754b8508329, topicName=脑血流)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b191324, createdName=marongnuan, createdTime=Sat Feb 20 12:07:00 CST 2016, time=2016-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35066, encodeId=6ff435066a8, content=期待有更多研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Thu Aug 06 23:03:00 CST 2015, time=2015-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1421022, encodeId=45681421022f6, content=<a href='/topic/show?id=09d33294eb8' target=_blank style='color:#2F92EE;'>#功能障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32947, encryptionId=09d33294eb8, topicName=功能障碍)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3493649807, createdName=naiwu78, createdTime=Wed Jul 15 03:07:00 CST 2015, time=2015-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=32638, encodeId=eed232638c3, content=完蛋咯, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150707/IMG559BDBCBCA5618647.jpg, createdBy=494c1631012, createdName=文刀, createdTime=Mon Jul 13 22:35:00 CST 2015, time=2015-07-13, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1999538, encodeId=f5881999538b1, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Wed Aug 19 15:07:00 CST 2015, time=2015-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2075889, encodeId=c73720e588947, content=<a href='/topic/show?id=b208891e986' target=_blank style='color:#2F92EE;'>#血流量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89179, encryptionId=b208891e986, topicName=血流量)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a691420, createdName=30397604, createdTime=Wed Jul 15 01:07:00 CST 2015, time=2015-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2042252, encodeId=1c70204225211, content=<a href='/topic/show?id=754b8508329' target=_blank style='color:#2F92EE;'>#脑血流#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85083, encryptionId=754b8508329, topicName=脑血流)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b191324, createdName=marongnuan, createdTime=Sat Feb 20 12:07:00 CST 2016, time=2016-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35066, encodeId=6ff435066a8, content=期待有更多研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Thu Aug 06 23:03:00 CST 2015, time=2015-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1421022, encodeId=45681421022f6, content=<a href='/topic/show?id=09d33294eb8' target=_blank style='color:#2F92EE;'>#功能障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32947, encryptionId=09d33294eb8, topicName=功能障碍)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3493649807, createdName=naiwu78, createdTime=Wed Jul 15 03:07:00 CST 2015, time=2015-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=32638, encodeId=eed232638c3, content=完蛋咯, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150707/IMG559BDBCBCA5618647.jpg, createdBy=494c1631012, createdName=文刀, createdTime=Mon Jul 13 22:35:00 CST 2015, time=2015-07-13, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1999538, encodeId=f5881999538b1, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Wed Aug 19 15:07:00 CST 2015, time=2015-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2075889, encodeId=c73720e588947, content=<a href='/topic/show?id=b208891e986' target=_blank style='color:#2F92EE;'>#血流量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89179, encryptionId=b208891e986, topicName=血流量)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a691420, createdName=30397604, createdTime=Wed Jul 15 01:07:00 CST 2015, time=2015-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2042252, encodeId=1c70204225211, content=<a href='/topic/show?id=754b8508329' target=_blank style='color:#2F92EE;'>#脑血流#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85083, encryptionId=754b8508329, topicName=脑血流)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b191324, createdName=marongnuan, createdTime=Sat Feb 20 12:07:00 CST 2016, time=2016-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35066, encodeId=6ff435066a8, content=期待有更多研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Thu Aug 06 23:03:00 CST 2015, time=2015-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1421022, encodeId=45681421022f6, content=<a href='/topic/show?id=09d33294eb8' target=_blank style='color:#2F92EE;'>#功能障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32947, encryptionId=09d33294eb8, topicName=功能障碍)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3493649807, createdName=naiwu78, createdTime=Wed Jul 15 03:07:00 CST 2015, time=2015-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=32638, encodeId=eed232638c3, content=完蛋咯, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150707/IMG559BDBCBCA5618647.jpg, createdBy=494c1631012, createdName=文刀, createdTime=Mon Jul 13 22:35:00 CST 2015, time=2015-07-13, status=1, ipAttribution=)]
    2015-08-06 hlycom3356

    期待有更多研究

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1999538, encodeId=f5881999538b1, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Wed Aug 19 15:07:00 CST 2015, time=2015-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2075889, encodeId=c73720e588947, content=<a href='/topic/show?id=b208891e986' target=_blank style='color:#2F92EE;'>#血流量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89179, encryptionId=b208891e986, topicName=血流量)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a691420, createdName=30397604, createdTime=Wed Jul 15 01:07:00 CST 2015, time=2015-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2042252, encodeId=1c70204225211, content=<a href='/topic/show?id=754b8508329' target=_blank style='color:#2F92EE;'>#脑血流#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85083, encryptionId=754b8508329, topicName=脑血流)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b191324, createdName=marongnuan, createdTime=Sat Feb 20 12:07:00 CST 2016, time=2016-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35066, encodeId=6ff435066a8, content=期待有更多研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Thu Aug 06 23:03:00 CST 2015, time=2015-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1421022, encodeId=45681421022f6, content=<a href='/topic/show?id=09d33294eb8' target=_blank style='color:#2F92EE;'>#功能障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32947, encryptionId=09d33294eb8, topicName=功能障碍)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3493649807, createdName=naiwu78, createdTime=Wed Jul 15 03:07:00 CST 2015, time=2015-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=32638, encodeId=eed232638c3, content=完蛋咯, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150707/IMG559BDBCBCA5618647.jpg, createdBy=494c1631012, createdName=文刀, createdTime=Mon Jul 13 22:35:00 CST 2015, time=2015-07-13, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1999538, encodeId=f5881999538b1, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Wed Aug 19 15:07:00 CST 2015, time=2015-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2075889, encodeId=c73720e588947, content=<a href='/topic/show?id=b208891e986' target=_blank style='color:#2F92EE;'>#血流量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89179, encryptionId=b208891e986, topicName=血流量)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a691420, createdName=30397604, createdTime=Wed Jul 15 01:07:00 CST 2015, time=2015-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2042252, encodeId=1c70204225211, content=<a href='/topic/show?id=754b8508329' target=_blank style='color:#2F92EE;'>#脑血流#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85083, encryptionId=754b8508329, topicName=脑血流)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b191324, createdName=marongnuan, createdTime=Sat Feb 20 12:07:00 CST 2016, time=2016-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35066, encodeId=6ff435066a8, content=期待有更多研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Thu Aug 06 23:03:00 CST 2015, time=2015-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1421022, encodeId=45681421022f6, content=<a href='/topic/show?id=09d33294eb8' target=_blank style='color:#2F92EE;'>#功能障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32947, encryptionId=09d33294eb8, topicName=功能障碍)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3493649807, createdName=naiwu78, createdTime=Wed Jul 15 03:07:00 CST 2015, time=2015-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=32638, encodeId=eed232638c3, content=完蛋咯, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150707/IMG559BDBCBCA5618647.jpg, createdBy=494c1631012, createdName=文刀, createdTime=Mon Jul 13 22:35:00 CST 2015, time=2015-07-13, status=1, ipAttribution=)]
    2015-07-13 文刀

    完蛋咯

    0

相关资讯

Cell:开启糖尿病个体化治疗的大门

来自宾夕法尼亚大学的研究人员揭示出,一种抗糖尿病药物会在个体间产生不同的疗效取决于一些微小的自然DNA序列变异。宾夕法尼亚大学Perelman医学院的Mitchell Lazar博士、Raymond Soccio博士和同事们,希望能够应用这一知识来开发出针对糖尿病和其他代谢性疾病的个体化疗法。研究小组将他们的结果发布在本周的《细胞》(Cell)杂志上。Lazar和研究小组将焦点放在了一种叫做P

JAMA:口服胰岛素胶囊或可有效控制糖尿病

近一个世纪以来,胰岛素被认为是挽救糖尿病人的重要疗法,而如今来自国外的研究人员验证了一项棘手的问题,即如果药片包含有给病人注射的相同药物,那么其是否可以用来帮助抑制糖尿病的发生,相关研究成果刊登于国际杂志Journal of the American Medical Association上。文章中研究者确定了这种新型策略是否可以帮助治疗1型糖尿病,一旦证实有效,那么这种疗法或许可以有效普及到1型

Anesth Analg:术前短期血糖控制可有效减少糖尿病围手术期感染

随着外科手术患者年龄范围逐渐扩大,因各种疾病需行手术治疗的糖尿病患者也日益增多。围手术期高血糖是糖尿病患者感染的独立危险因素,因为长期高血糖有利于细菌繁殖生长,加之糖尿病患者免疫功能低下,中性粒细胞功能异常、单核细胞活力下降、抗体生成减少、组织愈合能力差等,造成患有糖尿病的病人和动物更易在外科手术中出现细菌感染。 围手术期血糖的控制程度,决定患者术前等待时间长短、术后是否会出现各种并发症

Circulation:“香水有毒:Say no to含糖饮料”

背景:含糖饮料(SSBs)在全球畅销,过多饮用易导致肥胖。但是,关于目前在全球范围内畅销的含糖饮料,对肥胖相关的心血管疾病(CVD)、肿瘤及糖尿病的影响,尚无在国家、年龄、性别层次进行评估的相关研究。方法与结果:在2010年,我们在年龄/性别层次建立了全球、地区及国家范围内的与饮用含糖饮料相关的疾病模型。关于含糖饮料的消费情况,是从全球各国家有关饮食调查研究中获得的。在心血管疾病(CAD)方面,含

Diabetologia:铁缺乏导致HbA1c水平升高假象

目的:尽管使用HbA1c来诊断糖尿病已得到广泛认可,但是不可否认,HbA1c的水平受很多因素影响。贫血是主要的影响因素之一。关于红细胞指数及贫血的程度对HbA1c的影响仍不清楚。 方法:研究者对1990年1月至2014年5月期间,MEDL

还在幻想着“健康肥胖”?该醒醒了,伙计!

还在幻想着“健康肥胖”?该醒醒了,伙计! 英国的一项新的研究表明,“健康肥胖”只是一个幻想,大多数肥胖的人的身体会随着时间的推移逐渐变差,同时慢慢患上慢性疾病。“‘肥胖矛盾’的理论是指肥胖可能会提高某些人群的生存率,如心力衰竭患者。”伦敦大学学院流行病学和公共卫生系博士生,首席研究员Joshua Bell解释说。但是一项对2500余名英国人的健康进行了20年的追踪观察的研究发现,有一半的人群最初持

Baidu
map
Baidu
map
Baidu
map